Health and Fitness Health and Fitness
Tue, May 10, 2011
Mon, May 9, 2011
Sun, May 8, 2011
Sat, May 7, 2011
Fri, May 6, 2011
Thu, May 5, 2011
[ Thu, May 05th 2011 ] - Market Wire
Aetna and UPMC Sign Agreement
Wed, May 4, 2011
Tue, May 3, 2011
Mon, May 2, 2011
Fri, April 29, 2011
Thu, April 28, 2011
Wed, April 27, 2011
Tue, April 26, 2011
Mon, April 25, 2011
Fri, April 22, 2011
Thu, April 21, 2011
Wed, April 20, 2011
Tue, April 19, 2011
Mon, April 18, 2011
[ Mon, Apr 18th 2011 ] - Market Wire
00 a.m. ET
Sun, April 17, 2011
Fri, April 15, 2011
Thu, April 14, 2011
Wed, April 13, 2011
Tue, April 12, 2011

30 p.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2011


//health-fitness.news-articles.net/content/2011/ .. results-for-the-quarter-ended-march-31-2011.html
Published in Health and Fitness on Friday, April 22nd 2011 at 5:50 GMT by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the quarter ended March 31, 2011 after the U.S. financial markets close on May 3, 2011. The announcement will be followed by a conference call and webcast with slides at 4:30 p.m. ET during which management will discuss the Companya™s financial results, commercial progress and development programs.

To access the conference call via telephone, please dial (877) 412-6083 from the United States or (702) 495-1202 for international access. A telephone replay will be available from approximately 7:30 p.m. ET on May 3, 2011 through midnight May 5, 2011. To access a replay of the conference call, dial (800) 642-1687 from the United States or (706) 645-9291 for international access. The pass code for the live call and the replay is 57692403.

The call will be webcast with slides and accessible through the Investors section of the Companya™s website at [ www.amagpharma.com ]. The webcast replay will be available from approximately 7:30p.m. ET on May 3, 2011 through midnight June 3, 2011.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. AMAG manufactures and sells Feraheme® (ferumoxytol) Injection for intravenous use. For additional company or product information, please visit [ www.amagpharma.com ] or [ http://feraheme.com ].

Feraheme is a registered trademark of AMAG Pharmaceuticals, Inc.


Publication Contributing Sources